Bristol Myers Squibb (BMY) Protective Put Calculator
Calculator · free · no signup · BMYPrice a protective put, zero-cost collar, or put spread on Bristol Myers Squibb. Annual cost, max loss, upside cap, tax treatment, auto-filled from current BMY option chain.
AlphaLatitude Inc. · Free ToolsOur tools respect your browsing privacy. Independently verified:
You priced one hedge. The beta picks the right hedge structure given your full equity stack and tax situation.
Request beta access →Related calculators: Stock Concentration Calculator
About Bristol Myers Squibb
Bristol Myers Squibb (BMY) is a public Pharma/Biotech company, incorporated in Delaware and headquartered in Princeton, NJ.
Last close: $61.15 per share (as of 2026-10-04).
Equity grants at Bristol Myers Squibb typically include restricted stock units (RSUs).
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban (Eliquis) for people with atrial fibrillation ; nivolumab (Opdivo), used to treat certain types of cancer ; lenalidomide (Revlimid), used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes ; abatacept (Orencia), used to treat autoimmune diseases such as rheumatoid arthritis ; pomalidomide (Pomalyst/Imnovid), an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma ; ipilimumab (Yervoy), to treat cancer ; and luspatercept (Reblozyl) for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
Source: Wikipedia (CC BY-SA 4.0)
The modern company came from the 1989 merger of Bristol-Myers and Squibb, and its scale today rests on the 2019 acquisition of Celgene, which added Revlimid and the cell-therapy programs. The defining problem is patent expiry: Revlimid and Eliquis both face erosion, and the pipeline has to replace revenue on a schedule set by the calendar rather than by science. Business development is therefore structural rather than opportunistic. Immunology and oncology remain the therapeutic centers of gravity. Headquarters are in Princeton, New Jersey.
Sources: sec.gov · en.wikipedia.org
Equity comp at Bristol Myers Squibb
- Bristol Myers Squibb's change-in-control agreements use a double-trigger structure: outstanding RSUs and other equity awards accelerate and vest in full only if a change in control occurs AND the executive is involuntarily terminated without cause (or resigns for good reason) within 24 months afterward. No automatic single-trigger acceleration on the deal closing alone. The company also confirms no excise tax gross-ups on change-in-control parachute payments. Effective 2026, change-in-control severance for executive officers moved under a standardized Severance Benefits Plan, retaining the double-trigger design.
- RSUs use double-trigger vesting. Two things must both happen before the shares are yours: (1) the normal time-based vesting completes, and (2) the company has a liquidity event (an IPO or an acquisition). Until both happen, you do not yet own the shares and you do not owe tax on them.
Sources: sec.gov · sec.gov · sec.gov
Researched 2026-08-20.
OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by Bristol Myers Squibb.
A protective put caps your downside on the BMY position at a chosen floor; a zero-cost collar pays for that floor by capping the upside. This calculator prices both structures off the current BMY option chain, with annual cost, max loss, and tax-treatment notes.
Example: a 5,000-share BMY position at $61.15 is worth $305,750. A 1-year 30%-OTM put on that position typically runs 2-4% of position value per year (about $6,115 to $12,230) before any premium offset from a short call. The calculator prices both structures off BMY's current option chain so you see the actual cost for your chosen floor, tenor, and cap.
All Bristol Myers Squibb tools → · Use the generic Protect Your Stock Calculator for any company.
Bristol Myers Squibb equity questions
- How much does it cost to hedge BMY stock?
- The cost of a protective put depends on how far below the current price you set the floor, how long the protection lasts, and BMY's option-implied volatility. A zero-cost collar lowers that cost by selling away some upside. The calculator above prices both structures off the current BMY option chain and shows the annual cost, maximum loss, and tax treatment.
- Does Bristol Myers Squibb grant ISOs, NSOs, or RSUs?
- Equity compensation at Bristol Myers Squibb typically takes the form of restricted stock units (RSUs). Restricted stock units are taxed as ordinary income when they vest.
- Do Bristol Myers Squibb RSUs use double-trigger vesting?
- Yes. Bristol Myers Squibb restricted stock units (RSUs) vest only when two things both happen: the time-based schedule completes, and the company has a liquidity event such as an initial public offering (IPO) or an acquisition. Until both occur you do not own the shares and owe no tax on them.
Find another companyPharma/Biotech peers
One piece of the puzzle.
OptionsAhoy plans your Bristol Myers Squibb equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.